Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease.

Biochimica Et Biophysica Acta
Vik R Rajan, William E Mitch

Abstract

The ubiquitin-proteasome system (UPS) includes 3 enzymes that conjugate ubiquitin to intracellular proteins that are then recognized and degraded in the proteasome. The process participates in the regulation of cell metabolism. In the kidney, the UPS regulates the turnover of transporters and signaling proteins and its activity is down regulated in acidosis-induced proximal tubular cell hypertrophy. In chronic kidney disease (CKD), muscle wasting occurs because complications of CKD including acidosis, insulin resistance, inflammation, and increased angiotensin II levels stimulate the UPS to degrade muscle proteins. This response also includes caspase-3 and calpains which act to cleave muscle proteins to provide substrates for the UPS. For example, caspase-3 degrades actomyosin, leaving a 14 kDa fragment of actin in muscle. The 14 kDa actin fragment is increased in muscle of patient with kidney disease, burn injury and surgery. In addition, acidosis, insulin resistance, inflammation and angiotensin II stimulate glucocorticoid production. Glucocorticoids are also required for the muscle wasting that occurs in CKD. Thus, the UPS is involved in regulating kidney function and participates in highly organized responses that degrade m...Continue Reading

References

Jan 1, 1992·Annual Review of Genetics·S Jentsch
Sep 1, 1992·Kidney International·C T JurkovitzW E Mitch
Jul 1, 1990·Journal of the American Society of Nephrology : JASN·T H GoodshipV R Young
Jan 15, 1996·The Journal of Clinical Investigation·G TiaoP O Hasselgren
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·O MansoorD Attaix
May 1, 1996·Kidney International·K A GrahamT H Goodship
Dec 19, 1996·The New England Journal of Medicine·W E Mitch, A L Goldberg
Jul 1, 1997·The Journal of Clinical Investigation·N E TawaA L Goldberg
Oct 8, 1997·The American Journal of Physiology·H A FranchW E Mitch
Dec 9, 1997·Cell·G S Salvesen, V M Dixit
Feb 26, 1998·Cell·W BaumeisterE Seemüller
Jul 2, 1998·Kidney International·P L KimmelJ H Veis
May 18, 1999·The American Journal of Physiology·W E MitchS R Price
Apr 1, 1997·Journal of the American Society of Nephrology : JASN·K A GrahamT H Goodship
Feb 13, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J D Kopple
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·V H HaaseR Jaenisch
Mar 30, 2001·The Journal of Biological Chemistry·B MalikD C Eaton
Mar 29, 2002·Kidney International·Warren P PickeringJohn Walls
Aug 22, 2002·The Journal of Clinical Investigation·William E Mitch
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Josef CoreshAndrew S Levey
Jul 16, 2003·The Journal of Biological Chemistry·Joshua D Schnell, Linda Hicke
Jan 1, 2004·The Journal of Clinical Investigation·Jie DuWilliam E Mitch
Jan 14, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stewart H LeckerAlfred L Goldberg
Apr 17, 2004·Kidney International·George A KaysenUNKNOWN HEMO Study Group NIDDK
Apr 22, 2004·American Journal of Physiology. Endocrinology and Metabolism·Jennifer M SacheckAlfred L Goldberg
May 22, 2004·Journal of the American Society of Nephrology : JASN·Seoung Woo LeeWilliam E Mitch
Oct 14, 2004·Cell·Dongsheng CaiSteven E Shoelson
Nov 26, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Wei WeiPer-Olof Hasselgren
Jan 15, 2005·The Journal of Clinical Investigation·Yao-Hua SongPatrick Delafontaine
Feb 3, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Shuzo KobayashiToshio Ikeda

❮ Previous
Next ❯

Citations

Jan 12, 2011·Pflügers Archiv : European journal of physiology·Victoria C FolettaAaron P Russell
Jan 30, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Wai W CheungRobert H Mak
Nov 10, 2009·Current Hypertension Reports·Mark J Ranek, Xuejun Wang
Jul 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nitzan ShabekAaron Ciechanover
Aug 13, 2010·Seminars in Dialysis·Allon N Friedman
Jun 10, 2011·International Journal of Environmental Research and Public Health·Alice BonanniGiacomo Garibotto
Jun 12, 2012·Clinical and Experimental Nephrology·Hirotaka Fukasawa
Dec 1, 2010·Expert Opinion on Drug Discovery·Lyuben TsvetkovKenyon G Daniel
Mar 9, 2010·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Giacomo GaribottoDaniela Verzola
Jul 11, 2013·The International Journal of Biochemistry & Cell Biology·Biruh Workeneh, Mandeep Bajaj
Aug 6, 2016·Frontiers of Medicine·Yujiao LiuWei Li
May 3, 2018·Medicinal Research Reviews·Ribhav MishraAmit Mishra
Aug 26, 2014·Journal of the American Society of Nephrology : JASN·Mirela DobreThomas H Hostetter
Apr 12, 2014·Journal of the American Society of Nephrology : JASN·Maire BeekenCatherine Meyer-Schwesinger
May 8, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Giacomo GaribottoDaniela Verzola
Jul 6, 2018·Frontiers in Pediatrics·Franca M Iorember

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.